IDO1 and depressive symptom measurement: We observed that KYN/TRP of MDD patients were significantly higher, KYN/TRP frequently used as an index of IDO activity, Meta-analysis and previous studies have confirmed that patients with depression have higher KNN/TRP, which also indicates that increased neurotoxicity of downstream TRYCATs in MDD (38, 39).